Moody Aldrich Partners’s Encompass Health EHC Stock Holding History

Moody Aldrich Partners’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-20,942	Closed	-$676K	–	93
2016 Q3	$676K	Buy	20,942 +2,005	+11%	+$65K	0.47%	88
2016 Q2	$585K	Buy	18,937 +528	+3%	+$16.5K	0.48%	85
2016 Q1	$551K	Buy	+18,409	New	+$508K	1.16%	35

Other funds holding EHC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Moody Aldrich Partners's EHC Position: Q4 2016 in Review

Moody Aldrich Partners sold out of Encompass Health (EHC) in Q4 2016, closing a stake of 20,942 shares — an estimated $676K sold.

Moody Aldrich Partners first reported a position in EHC in Q1 2016 and held it in 3 quarters. The position peaked at $676K in Q3 2016. 321 funds tracked by Wall St. Rank hold EHC as of Q4 2016.

Moody Aldrich Partners reported no remaining Encompass Health position as of Q4 2016 after selling out during the quarter.
Moody Aldrich Partners sold 20,942 Encompass Health shares in Q4 2016, an estimated $676K.
Moody Aldrich Partners first reported a position in Encompass Health in Q1 2016 and held it in 3 quarters.
Moody Aldrich Partners's Encompass Health position peaked at $676K in Q3 2016.
321 funds tracked by Wall St. Rank held Encompass Health as of Q4 2016.

Based on Moody Aldrich Partners's 13F filing for Q4 2016, filed 17 Jan 2017.